X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Why drug importation threatens patient safety

By Allyson Funk  |    February 28, 2017
Counterfeit drug manufacturing and trafficking is a multi-billion dollar business. Legislative proposals to allow importation of potentially counterfeit and substandard drugs into the United...   Read More

Rare Disease Day: Accelerating innovation for patients in need

By Anne McDonald Pritchett, PhD  |    February 28, 2017
As we celebrate Rare Disease Day, it is important to not only reflect on how far we have come in tackling these devastating and complex conditions, but how much unmet medical remains. While more...   Read More

Medicare Monday: There’s an agency called MedPAC?

By Nicole Longo  |    February 27, 2017
Now that we’ve learned more about IPAB and CMMI, there’s one more agency on our list to read up on this month – the Medicare Payment Advisory Commission (MedPAC).   Read More

Fact Check Friday: The truth about drug importation and patient safety

By Allyson Funk  |    February 24, 2017
This week on Fact Check Friday, we’re discussing the truth about proposals to allow the importation of medicines from other countries and what these proposals mean for patients. MYTH: Importation...   Read More

How do multiple sclerosis patients define value?

By Lauren Neves  |    February 24, 2017
There are crucial conversations occurring in the health care system about how value is defined. To explore how multiple sclerosis (MS) patients, providers and payers view value, Real Endpoints...   Read More

PPA: 2016 in review

By Hannah Mooney  |    February 23, 2017
More than a decade has passed since the Partnership for Prescription Assistance (PPA) launched. In this time, PPA has helped nearly 10 million patients through its free and confidential program,...   Read More

ICYMI: New era of medicine initiative kicks off in Boston

By Andrew Powaleny  |    February 22, 2017
It’s no secret that Boston, Massachusetts is home to many of the most groundbreaking advancements in medical discovery. That’s why yesterday, PhRMA sponsored its first national health care...   Read More

Exploring the new era of medicine

By Bill Chin, M.D.  |    February 21, 2017
We are in a new era of medicine where innovations are transforming our ability to attack the cause of disease, not just the symptoms. Where treatment decisions are increasingly focused on the...   Read More

Medicare Monday: Have you heard of CMMI?

By Nicole Longo  |    February 20, 2017
There are a number of acronyms commonly used in the health care world, which can often be confusing and complicated, so this week we’re tackling one of them: CMMI.   Read More

ICYMI – 3 new reports show dramatic slowdown in medicine spending growth

By Holly Campbell  |    February 17, 2017
Newly released government actuary and pharmacy benefit manager data confirm previous projections of a significant decline in medicine spending growth. After accounting for discounts and rebates,...   Read More

What you don’t know about importation from Canada

By Allyson Funk  |    February 17, 2017
Proposals to allow the importation of prescription medicines from Canada ignore the dangerous threat to patients of counterfeit and adulterated medicines. What actually happens when a patient...   Read More

Biopharmaceutical industry’s success reducing disparities for African Americans

By Myisha Gatson  |    February 16, 2017
February is Black History Month, and here at PhRMA, we continue our decades-long commitment to reducing disparities in health care for minorities through developing and helping communities access...   Read More

Guest Post: Johnson and Johnson is celebrating outstanding scientists: Who will be next?

By Guest Contributor  |    February 15, 2017
As a health care company with the mission of bringing forward transformational solutions for patients and consumers, innovative scientific advances are the essence of our success. We believe that...   Read More

Watch: Biomarkers in drug development with Dr. Bernie Zeiher

By Andrew Powaleny  |    February 14, 2017
Biomarkers are powerful tools which are used by medical professionals in many ways, including in the diagnosis of disease, monitoring how a disease is progressing and, if a treatment is given, how...   Read More

Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients

By Nicole Longo  |    February 13, 2017
The manufacturing and trafficking of counterfeit drugs is not just a U.S. concern but a growing threat globally. Governments around the world are working together to try to prevent these fake...   Read More

Medicare Monday: What is IPAB, and why is it bad for patients?

By Nicole Longo  |    February 13, 2017
In 2017, the Independent Payment Advisory Board (IPAB)couldfinally go into effect and come between patients and their health care providers. This week, we’re looking into this dangerous body.     Read More

PhRMA urges USTR to protect American innovators abroad

By Mark Grayson  |    February 10, 2017
Yesterday, PhRMA submitted comments for the 2017 Special 301 Report the Office of the U.S. Trade Representative (USTR) will publish in April. The comments highlight serious intellectual property...   Read More

340B Spotlight: Audit findings show importance of increased oversight of 340B program

By Rebecca Davison  |    February 9, 2017
The 340B Drug Discount Program is an important component of the health care safety net, providing help to vulnerable or uninsured patients. However, with great power comes great responsibility,...   Read More

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

By Holly Campbell  |    February 9, 2017
Following the biopharmaceutical industry’s recent meeting with President  Donald J. Trump, PhRMA president and CEO Stephen J. Ubl joined Dan Diamond on POLITICO’s Pulse Check podcast to discuss...   Read More

VIDEO: PhRMA CEO joins Fox Business anchor Neil Cavuto to discuss personal connection to value of innovation and White House meeting

By Holly Campbell  |    February 6, 2017
PhRMA president and CEO Stephen J. Ubl recently spoke with FOX Business anchor Neil Cavuto on his personal connection to the value of medical technology with his son’s type 1 diabetes diagnosis,...   Read More

Medicare Monday: Did you know … ?

By Nicole Longo  |    February 6, 2017
On Medicare Monday, we talk a lot about Medicare Part D and how it works, but here are five things you might not know about the program.   Read More

This is not a video game: New TV ad showcases the destruction of a cancer cell by immune system

By Robert Zirkelbach  |    February 5, 2017
Today, as part of our new advertising and public affairs initiative, GOBOLDLY™, we are excited to announce the premier of our newest TV advertisement, Cells, which highlights innovative...   Read More

VIDEO: PhRMA CEO discusses #GOBOLDLY campaign and White House meeting with CNNMoney’s Maggie Lake

By Holly Campbell  |    February 3, 2017
PhRMA president and CEO Stephen J. Ubl joined Maggie Lake on CNNMoney this week to talk about the industry’s new national campaign, GOBOLDLY™, and meeting with President Donald J. Trump. He also...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates